Výsledky vyhledávání - "Maxim Kebenko"

Akademický článek

Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study

Autor: Linda Preyer, Eik Vettorazzi, Walter Fiedler, Holger Rohde, Jannik Stemler, Saskia Gönner, Carsten Bokemeyer, Cyrus Khandanpour, Friederike Wortmann, Maxim Kebenko

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

IntroductionOur monocentric and retrospective study aimed to investigate the clinical effectivity of HEPA filters in combination with the antifungal drug prophylaxis in patients with AML undergoing intensive chemotherapy and allogeneic stem cell tran

Externí odkaz: https://doaj.org/article/f71685be7836476aa4c9e713e2af08b3

Zobrazit plný text záznamu

Akademický článek

Case report: Tenosynovial giant cell tumor

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

Tenosynovial giant cell tumor (TGCT) is a rare type of tumor that originates from the synovium of joints and tendon sheaths. It is characterized by recurring genetic abnormalities, often involving the CSF1 gene. Common symptoms include pain and swell

Externí odkaz: https://doaj.org/article/40b1b72d680f47c2a37a910d9ae3158d

Zobrazit plný text záznamu

Akademický článek

A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors

Autor: Maxim Kebenko, Marie-Elisabeth Goebeler, Martin Wolf, Annette Hasenburg, Ruth Seggewiss-Bernhardt, Barbara Ritter, Beate Rautenberg, Djordje Atanackovic, Andrea Kratzer, James B. Rottman, Matthias Friedrich, Eva Vieser, Stefanie Elm, Ingrid Patzak, Dorothea Wessiepe, Sabine Stienen, Walter Fiedler

Publikováno v: OncoImmunology, Vol 7, Iss 8 (2018)

We assessed the tolerability and antitumor activity of solitomab, a bispecific T-cell engager (BiTE®) antibody construct targeting epithelial cell adhesion molecule (EpCAM). Patients with relapsed/refractory solid tumors not amenable to standard the

Externí odkaz: https://doaj.org/article/c25399b4cdbf40faa991efa0e3c720c6

Zobrazit plný text záznamu

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial

Autor: Viktor Grünwald, Daniel Pink, Gerlinde Egerer, Enrico Schalk, Marinela Augustin, Christoph K. W. Deinzer, Viola Kob, Dietmar Reichert, Maxim Kebenko, Stephan Brandl, Dennis Hahn, Lars H. Lindner, Mathias Hoiczyk, Uta Ringsdorf, Lars C. Hanker, Dirk Hempel, Beatriz De Rivas, Tobias Wismann, Philipp Ivanyi

Publikováno v: Cancers; Volume 14; Issue 21; Pages: 5234

This non-interventional, prospective phase IV trial evaluated trabectedin in patients with soft tissue sarcoma (STS) in real-life clinical practice across Germany. The primary endpoints were progression-free survival (PFS) rates at 3 and 6 months, as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84365cacc06a13c5327a9b98c4b57a49
https://doi.org/10.3390/cancers14215234

Zobrazit plný text záznamu

Plný text ve formátu HTML

Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)

Autor: Maxim Kebenko, Dimosthenis Andreou, Sebastian Bauer, Peter Hohenberger, Stephan Richter, Lars H. Lindner, Peter Reichardt, Joanna Szkandera, Marietta Kirchner, Bernd Kasper, Daniel Pink, Thomas Brodowicz, Viktor Grünwald

Publikováno v: Cancers, Vol 13, Iss 1223, p 1223 (2021)
Cancers
Volume 13
Issue 6

We aimed to evaluate the efficacy and toxicity of paclitaxel combined with pazopanib in advanced angiosarcoma (AS). The primary end point was progression-free survival (PFS) rate at six months (PFSR6). Planned accrual was 44 patients in order to dete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b99d0f5d237f9f890a079cfab122a69
https://www.mdpi.com/2072-6694/13/6/1223

Zobrazit plný text záznamu

Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient

Autor: Daniel, Pink, Dimosthenis, Andreou, Sebastian, Bauer, Thomas, Brodowicz, Bernd, Kasper, Peter, Reichardt, Stephan, Richter, Lars H, Lindner, Joanna, Szkandera, Viktor, Grünwald, Maxim, Kebenko, Marietta, Kirchner, Peter, Hohenberger

Publikováno v: Cancers

Simple Summary There are very few systemic treatment options for patients with advanced angiosarcomas. We therefore examined whether combined treatment with paclitaxel and pazopanib was active and well tolerated. However, we did not meet a preplanned

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cdba39c57911f596dc1771c9ab22d751
https://pubmed.ncbi.nlm.nih.gov/33799576

Zobrazit plný text záznamu

Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia

Autor: Jana Muschhammer, Carsten Bokemeyer, Gabi Vohwinkel, Walter Fiedler, Jasmin Wellbrock, Manfred Jücker, Hauke Stamm, Maxim Kebenko, Emily-Marie Latuske, Marianne Klokow

Publikováno v: Oncotarget

// Emily-Marie Latuske 1 , Hauke Stamm 1 , Marianne Klokow 1 , Gabi Vohwinkel 1 , Jana Muschhammer 1 , Carsten Bokemeyer 1 , Manfred Jucker 2 , Maxim Kebenko 1 , Walter Fiedler 1 , Jasmin Wellbrock 1 1 Department of Oncology, Hematology and Bone Marr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b112312c82e3dce873e79c29833f45c
https://doi.org/10.18632/oncotarget.16304

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání